N. Tanno

发表

Tricyclic quinoxalinediones: 5,6-dihydro-1H-pyrrolo[1,2,3-de] quinoxaline-2,3-diones and 6,7-dihydro-1H,5H-pyrido[1,2,3-de] quinoxaline-2,3-diones as potent antagonists for the glycine binding site of the NMDA receptor.

T. Kato, R. Nagata, H. Yamaguchi, 1994, Journal of medicinal chemistry.

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-HT 7 and 5-HT 1A Receptor Activity

Mitsutaka Nakamura, M. Ogasa, Y. Ohno, 2010 .

[Studies on beta-lactam antibiotics. V. Synthesis of 6-[D(-)-alpha-(acylamino)-4-hydroxyphenylacetamido]penicillanic acids and antibacterial activity (author's transl)].

H. Noguchi, H. Yamada, N. Tanno, 1980, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Stereospecific total synthesis of 9-aminoanthracyclines: (+)-9-amino-9-deoxydaunomycin and related compounds

N. Ohashi, N. Tanno, K. Ishizumi, 1987 .

Asymmetric reduction of αβ-unsaturated ketones with lithium aluminium hydride partially decomposed by (–)-N-methylephedrine and N-ethylaniline

K. Koga, S. Terashima, N. Tanno, 1980 .

Structure-activity relationships of tricyclic quinoxalinediones as potent antagonists for the glycine binding site of the NMDA receptor 2

R. Nagata, H. Yamaguchi, N. Tanno, 1995 .

Asymmetric Synthesis of optically Active Anthracyclinone Intermediate and 4-Demethoxyanthracyclinones by the Use of a Novel Chiral Reducing Agent

S. Terashima, N. Tanno, 1983 .

Deprotection of 4-methoxybenzyloxycarbonyl group with p-toluenesulfonic acid in acetonitrile: application to a large-scale preparation of 7-[D-2-amino-2-(4-hydroxyphenyl)acetamido]cephalosporanic acid

N. Tanno, H. Tobiki, S. Ueda, 1984 .

[Studies on beta-lactam antibiotics. IV. Synthesis of apalcillin (author's transl)].

H. Yamada, H. Suzuki, N. Tanno, 1980, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

A novel synthesis of (±)-2-acetyl-5,8-dimethoxy-1,2,3,4-tetrahydro-2-naphthol, a key intermediate for the synthesis of anthracyclinones

K. Koga, S. Terashima, N. Tanno, 1980 .

SYNTHESIS OF (‐)‐HYOSAMINE AND (‐)‐4‐DEOXYSTREPTAMINE

K. Rinehart, S. Ogawa, T. Suami, 1974 .

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Hitomi Oki, Yukihiro Ohno, Kenji Matsumoto, 2010, Journal of Pharmacology and Experimental Therapeutics.

Asymmetric Reduction of Various Types of Ketones with Lithium Aluminum Hydride partially decomposed with (-)-N-Methylephedrine and N-Ethylaniline

S. Terashima, N. Tanno, 1983 .

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Kenji Matsumoto, Y. Ohno, Mitsutaka Nakamura, 2010, Journal of Pharmacology and Experimental Therapeutics.

Asymmetric synthesis of optically pure (R)(−)-2-acetyl-5,8-dimethoxy-1,2,3,4-tetrahydro-2-naphthol, a key intermediate for optically active anthracyclinone synthesis

K. Koga, S. Terashima, N. Tanno, 1980 .